-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
GoodRx Holdings, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2019 to Q2 2024.
- GoodRx Holdings, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $4.95M.
- GoodRx Holdings, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$618K, a 97.3% increase year-over-year.
- GoodRx Holdings, Inc. annual Income Tax Expense (Benefit) for 2023 was -$46.7M, a 587% decline from 2022.
- GoodRx Holdings, Inc. annual Income Tax Expense (Benefit) for 2022 was $9.6M, a 36.3% decline from 2021.
- GoodRx Holdings, Inc. annual Income Tax Expense (Benefit) for 2021 was $15.1M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)